Article
Potential application of Leishmania tarentolae as an alternative platform for antibody expression
5 Feb 2019
Abstract excerpt
Through the discovery of monoclonal antibody (mAb) technology, profound successes in medical treatment against a wide range of diseases have been achieved. This has led antibodies to emerge as a new class of biodrugs. As the "rising star" in the pharmaceutical market, extensive research and development in antibody production has been carried out in various expression systems including bacteria, insects, plants,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
